• Studying the Safety of Aripiprazole and Risperidone in Children and Adolescents with Autism Spectrum Disorder

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands

  • Study on the Effects of Abacavir and Lamivudine in Patients with Systemic Lupus Erythematosus with Low Disease Activity

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Safety and Effectiveness of Methylprednisolone Sodium Succinate and Sodium Chloride for Patients with Severe Cardiac Inflammation

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Finland Italy Slovenia +2

  • Study on Budesonide for COPD Patients with Different Eosinophil Levels

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany The Netherlands Spain

  • Study on Clioquinol for Reducing Seizures in Patients with Drug-Resistant Epilepsy

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on the Effects of Dapagliflozin for Patients with Refractory Heart Failure

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Long-Term Safety of Futibatinib and Fulvestrant for Patients with Malignant Solid Tumors

    Recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Portugal Spain Sweden

  • Study on the Effects of Oral Semaglutide on Bone Health in Patients with Type 2 Diabetes and Low Bone Mass

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Apremilast for Treating Oral Ulcers in Children with Behçet’s Disease

    Recruiting

    3 1
    Investigated drugs:
    France Greece Italy Spain

  • Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

powered by